Giuseppe Manfroni

Prof. Dr. Giuseppe Manfroni

Department of Pharmaceutical Sciences, University of Perugia, 06123 Perugia, Italy
orcid

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 July 2011 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
SSStefano Sabatini
Stefano Sabatini
FGFrancesca Gosetto
Francesca Gosetto
Giuseppe ManfroniGiuseppe Manfroni
Giuseppe Manfroni
Oriana TabarriniOriana Tabarrini
Oriana Tabarrini
GKGlenn W. Kaatz
Glenn W. Kaatz
VCVioletta Cecchetti
Violetta Cecchetti

3 April 2012 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
SSStefano Sabatini
Stefano Sabatini
FGFrancesca Gosetto
Francesca Gosetto
SSSerena Serritella
Serena Serritella
Giuseppe ManfroniGiuseppe Manfroni
Giuseppe Manfroni
Oriana TabarriniOriana Tabarrini
Oriana Tabarrini
VCVioletta Cecchetti
Violetta Cecchetti

20 April 2015 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
Serena MassariSerena Massari
Serena Massari
Giulio NannettiGiulio Nannetti
Giulio Nannetti
JDJenny Desantis
Jenny Desantis
GMGiulia Muratore
Giulia Muratore
SSStefano Sabatini
Stefano Sabatini
Oriana TabarriniOriana Tabarrini
Oriana Tabarrini

1 October 2016 in Antiviral Research
Verified
Journal Article
Open access
DTDelia Tarantino
Delia Tarantino
RCRolando Cannalire
Rolando Cannalire
EMEloise Mastrangelo
Eloise Mastrangelo
RCRomina Croci
Romina Croci
GQGilles Querat
Gilles Querat
Mario MilaniMario Milani
Mario Milani
RNA dependent RNA polymerases (RdRp) are essential enzymes for flavivirus replication. Starting from an in silico docking analysis we identified a pyridobenzothiazole compound, HeE1-2Tyr, able to inhibit West Nile and Dengue RdRps activity in vitro, which proved effective against different flaviviruses in cell culture. Crystallographic data show that HeE1-2Tyr binds between the fingers domain and the priming loop of Dengue virus RdRp (Site 1). Conversely, enzyme kinetics, binding studies and mutational analyses suggest that, during the catalytic cycle and assembly of the RdRp-RNA complex, HeE1-2Tyr might be hosted in a distinct binding site (Site 2). RdRp mutational studies, driven by in silico docking analysis, allowed us to locate the inhibition Site 2 in the thumb domain. Taken together, our results provide innovative concepts for optimization of a new class of anti-flavivirus compounds.

22 March 2006 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
Oriana TabarriniOriana Tabarrini
Oriana Tabarrini
Giuseppe ManfroniGiuseppe Manfroni
Giuseppe Manfroni
AFArnaldo Fravolini
Arnaldo Fravolini
VCVioletta Cecchetti
Violetta Cecchetti
SSStefano Sabatini
Stefano Sabatini
JNJohan Hendrik Neyts
Johan Hendrik Neyts

8 December 2010 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
JBJean Pierre Brincat
Jean Pierre Brincat
ECEmanuele Carosati
Emanuele Carosati
SSStefano Sabatini
Stefano Sabatini
Giuseppe ManfroniGiuseppe Manfroni
Giuseppe Manfroni
AFArnaldo Fravolini
Arnaldo Fravolini
GCGabriele Cruciani
Gabriele Cruciani